Correlation Between B Communications and Teva Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both B Communications and Teva Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining B Communications and Teva Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between B Communications and Teva Pharmaceutical Industries, you can compare the effects of market volatilities on B Communications and Teva Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in B Communications with a short position of Teva Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of B Communications and Teva Pharmaceutical.

Diversification Opportunities for B Communications and Teva Pharmaceutical

-0.78

Correlation Coefficient

B Communications  Teva Pharmaceutical

Pay attention - limited upside

The 3 months correlation between BCOM and Teva is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding B Communications and Teva Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharmaceutical and B Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on B Communications are associated (or correlated) with Teva Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharmaceutical has no effect on the direction of B Communications i.e., B Communications and Teva Pharmaceutical go up and down completely randomly.

Pair Corralation between B Communications and Teva Pharmaceutical

Assuming the 90 days trading horizon B Communications is expected to generate 1.17 times more return on investment than Teva Pharmaceutical. However, B Communications is 1.17 times more volatile than Teva Pharmaceutical Industries. It trades about 0.35 of its potential returns per unit of risk. Teva Pharmaceutical Industries is currently generating about -0.08 per unit of risk. If you would invest  150,900  in B Communications on September 13, 2024 and sell it today you would earn a total of  25,500  from holding B Communications or generate 16.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	94.74%
Values	Daily Returns

B Communications  vs.  Teva Pharmaceutical Industries

B Communications

Risk-Adjusted Performance

30 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in B Communications are ranked lower than 30 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, B Communications sustained solid returns over the last few months and may actually be approaching a breakup point.

Teva Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Teva Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with B Communications and Teva Pharmaceutical

The main advantage of trading using opposite B Communications and Teva Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if B Communications position performs unexpectedly, Teva Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharmaceutical will offset losses from the drop in Teva Pharmaceutical's long position.

The idea behind B Communications and Teva Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.